tirzepatide news october 18 2025 FDA Grants a New Indication for Obesity Management Lilly, Novo Fight Weight Loss

The operation was producing counterfeit versions of a renal and a neurological drug, as well as an anti-inflammatory

Verify state availability: Confirm the program services are available in your specific state before beginning the intake process

In our experience, some powders require extra stirring or shaking to achieve optimal solubility

Food and Drug Administration (FDA), the medications are used for chronic weight management in adults with obesity or who are overweight with a weight-related condition, including high blood pressure or type 2 diabetes

Clinically, patients report greater satiety and reduced hunger, even during significant weight loss

Zepbound contains the same active ingredient, tirzepatide, but the FDA specifically approves it for chronic weight management